JTC Employer Solutions Trustee’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84K Hold
2,658
– – 0.01% 214
2026
Q1
$80K Hold
2,658
– – 0.01% 219
2025
Q4
$92K Hold
2,658
– – 0.01% 215
2025
Q3
$96K Hold
2,658
– – 0.01% 210
2025
Q2
$84K Hold
2,658
– – 0.01% 204
2025
Q1
$79K Hold
2,658
– – 0.01% 209
2024
Q4
$77K Hold
2,658
– – 0.01% 218
2024
Q3
$83K Sell
2,658
-1,250
-32% -$45.5K 0.01% 220
2024
Q2
$132K Hold
3,908
– – 0.01% 165
2024
Q1
$248K Hold
3,908
– – 0.02% 116
2023
Q4
$268K Hold
3,908
– – 0.02% 105
2023
Q3
$203K Hold
3,908
– – 0.02% 128
2023
Q2
$234K Hold
3,908
– – 0.02% 114
2023
Q1
$193K Hold
3,908
– – 0.02% 136
2022
Q4
$223K Buy
+3,908
New +$220K 0.02% 115

Other funds holding IMCR

JTC Employer Solutions Trustee's IMCR Position: Q2 2026 in Review

JTC Employer Solutions Trustee held its Immunocore (IMCR) position steady in Q2 2026 at 2,658 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #214.

JTC Employer Solutions Trustee first reported a position in IMCR in Q4 2022 and has held it in 15 quarters since. The position peaked at $268K in Q4 2023. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • JTC Employer Solutions Trustee held 2,658 shares of Immunocore worth $84K as of Q2 2026.
  • JTC Employer Solutions Trustee left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up 0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #214 holding.
  • JTC Employer Solutions Trustee first reported a position in Immunocore in Q4 2022 and has held it in 15 quarters since.
  • JTC Employer Solutions Trustee's Immunocore position peaked at $268K in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.